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ABSTRACT 
Myosin-binding protein-C (cMyBP-C) is a key 
regulator of contractility in heart muscle, and its 
regulatory function is controlled in turn by 
phosphorylation of multiple serines in its m-
domain. The structural and functional effects of 
m-domain phosphorylation have often been 
inferred from those of the corresponding serine-
to-aspartate (S–D) substitutions, in both in vivo 
and in vitro studies. Here, using a combination of 
in vitro binding assays and in situ structural and 
functional assays in ventricular trabeculae of rat 
heart and the expressed C1mC2 region of 
cMyBP-C, containing the m-domain flanked by 
domains C1 and C2, we tested whether these 
substitutions do in fact mimic the effects of 
phosphorylation. In situ changes in thin and thick 
filament structure were determined from changes 
in polarized fluorescence from bifunctional 
probes attached to troponin C or myosin 
regulatory light chain, respectively. We show that 
both the action of exogenous C1mC2 to activate 
contraction in the absence of calcium and the 
accompanying change in thin filament structure 
are abolished by tris-phosphorylation of the m-
domain, but unaffected by the corresponding S–
D substitutions. The latter produced an 
intermediate change in thick filament structure. 
Both tris-phosphorylation and S–D substitutions 
abolished the interaction between C1mC2 and 
myosin sub-fragment 2 (myosin S2) in vitro, but 
yielded different effects on thin filament binding. 
These results suggest that some previous 
inferences from the effects of S–D substitutions 
in cMyBP-C should be reconsidered and that the 
distinct effects of tris-phosphorylation and S–D 
substitutions on cMyBP-C may provide a useful 
basis for future studies. 
 
 
Phosphorylation of cardiac myosin binding 
protein-C (cMyBP-C) is an important 
determinant of cardiac muscle function, and 
ablation of cMyBP-C phosphorylation has 
frequently been associated with heart failure, 
further underlining its functional significance (1). 
cMyBP-C is phosphorylated in vivo (2) and is a 
substrate for multiple protein kinases that target 
conserved serine residues in the m-domain or m-
motif that links the C1 and C2 Ig domains (Fig. 
1A)  (3). Phosphorylation of these residues 
controls the interaction of the N-terminal region 
of cMyBP-C with both the myosin-containing 
thick and the actin-containing thin filaments (4). 
Interactions of cMyBP-C’s N-terminal domains 
with myosin are thought to have mainly inhibitory 
effects on contractility by stabilizing the thick 
filament OFF state, characterized by myosin head 
domains bound to the filament core in quasi-
helical tracks (5,6). In contrast, cMyBP-C-actin 
interactions have been frequently associated with 
an activating effect on contractility and thin 
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filament structure (5,7). Phosphorylation of 
cMyBP-C has been shown to abolish these 
regulatory interactions and therefore modulate 
cardiac contractility via changes in the thick and 
thin filament regulatory state. 
Serine to aspartate (S-D) substitutions of serine 
residues within the m-motif have often been used 
as a proxy for phosphorylation, in vivo in 
transgenic animal models (8,9), in situ in isolated 
cardiac muscle cells (10), and in vitro in isolated 
proteins (11,12). The assumption that S-D 
substitutions reproduce the effects of 
phosphorylation in cMyBP-C has generally not 
been critically examined. In vivo experiments on 
transgenic animal lines do not allow direct 
comparison of the effects of fully phosphorylated 
and S-D substituted cMyBP-C on cardiac muscle 
function. In contrast, in vitro experiments using 
isolated proteins allow some functional 
mechanisms to be characterized at the molecular 
level, but do not reproduce regulatory and 
contractile mechanisms that depend on the native 
lattice of thick and thin filaments. 
In this study, we used bifunctional fluorescent 
probes on myosin regulatory light chain (RLC) or 
troponin C (TnC) to monitor structural changes in 
the thick and thin filaments respectively in rat 
heart muscle cells. We induced activation of the 
muscle cells using exogenous rat cardiac C1mC2 
fragments that were native, tris-phosphorylated or 
carrying three S-D substitutions. We combined 
these structural measurements with 
measurements of active isometric force, and with 
biochemical characterization of the interaction 
between C1mC2 and myosin S2, and C1mC2 and 
native thin filaments (NTF) in vitro, to determine 
whether S-D substitutions reproduce the 
structural and functional effects of 
phosphorylation. 
 
Results 
Phospho-mimetic substitutions in C1mC2 do not 
abolish thin filament activation 
N-terminal fragments of rat cardiac myosin 
binding protein-C containing the Ig-domains C1 
and C2, and the intervening m-domain (C1mC2) 
are sufficient to activate contraction of 
demembranated rat ventricular trabeculae in the 
absence of Ca2+, and tris-phosphorylation of 
C1mC2 by PKA (Protein Kinase A) abolishes this 
effect (5). This assay therefore enables a test of 
the ability of serine-to-aspartate (S-D) 
substitutions to act as phospho-mimetics for this 
mode of action of cMyBP-C. Trabeculae were 
incubated in relaxing solution (pCa 9) containing 
40 µmol/L unphosphorylated C1mC2, PKA tris-
phosphorylated C1mC2 (C1mC2-3P; Fig. S1) or 
C1mC2 with three phosphorylatable serines 
mutated to aspartate (C1mC2-3SD) (Fig. 1). 
Incubation in C1mC2 produced an isometric 
force of 57 ± 5% (mean ± SEM, n=13) of that 
during full Ca2+ activation (Fig. 1B), whereas 
C1mC2-3P produced no activation, as described 
previously (5). Strikingly, C1mC2-3SD activated 
contraction to the same extent as C1mC2 (57 ± 
5%, mean ± SEM, n=13). In complete contrast to 
phospho-serines, the S-D substitutions have no 
effect on the activating effect of C1mC2. 
We used bifunctional (sulfo)rhodamine probes 
attached to either the E-helix of cardiac troponin 
C (BR-cTnC-E) or crosslinking helices B and C 
of cardiac myosin regulatory light chain (BSR-
cRLC-BC) (Fig. S2) to monitor structural 
changes in the thin and thick filaments, 
respectively, in this assay. The cTnC E-helix is 
part of the IT-arm of troponin and its orientation 
is coupled to the position of tropomyosin on the 
surface of the thin filament. The order parameter 
<P2> describing the orientation of BR-cTnC-E 
decreases on calcium activation, suggesting a 
more perpendicular orientation of the E-helix 
(Fig. 1C). Incubation of BR-cTnC-E exchanged 
trabeculae in relaxing solution (pCa 9) containing 
40 µmol/L C1mC2 induced a change in thin 
filament structure reported by the TnC E-helix 
probe that is significantly larger than that during 
full calcium activation, as reported previously (5). 
In contrast with unphosphorylated C1mC2, 
C1mC2-3P had no effect on thin filament 
structure. However C1mC2-3SD had the same 
effect as C1mC2 (Fig. 1C). Thus, in full 
agreement with the functional effects described 
above, the S-D substitutions do not reproduce the 
effect of tris-phosphorylation of C1mC2 on thin 
filament structure.  
The RLC BC-helix probe is mainly sensitive to 
the regulatory state of the thick filament (13), and 
<P2> for this probe increases on calcium 
activation (Fig. 1D). Incubation of BSR-cRLC-
BC exchanged trabeculae in 40 µmol/L C1mC2 
induced a change in BSR-cRLC-BC probe 
orientation of ~70% of that for calcium 
activation, whereas C1mC2-3P produced no 
significant change in probe orientation. C1mC2-
3SD had an intermediate effect. 
The above results show that the S-D substitutions 
in C1mC2 do not mimic the effects of tris-
phosphorylation for the active force and 
accompanying effects on thin and thick filament 
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structure induced by C1mC2 in the absence of 
calcium. For active force and thin filament 
structure, the action of C1mC2-3SD was 
indistinguishable from that of the native 
fragment. For thick filament structure, the effect 
was intermediate, suggesting the possibility that 
S-D substitutions in the m-domain might mimic 
phosphorylation of these residues with respect to 
the direct action of C1mC2 on thick but not thin 
filament structure, in the light of previous 
evidence for coupling between the regulatory 
states of the thin and thick filaments (5,14).  
 
Phospho-mimetic substitutions in C1mC2 alter 
thin filament interaction and abolish binding to 
myosin S2 
We used high-velocity co-sedimentation to 
determine the effects of phosphorylation and S-D 
substitutions in C1mC2 on binding to isolated 
native thin filaments (NTF). The 
unphosphorylated C1mC2 binds NTFs in a 
saturable manner with a Kd of 23 ± 7 µmol/L 
(mean ± SEM, n=7) and Bmax of 0.81 ± 0.10 
mol/mol, suggesting roughly stoichiometric 
binding of C1mC2 to actin (Fig. 2A). PKA tris-
phosphorylation of C1mC2 increased Kd to 57 ± 
5 µmol/L (mean ± SEM, n=8) and reduced Bmax 
to 0.67 ± 0.06 mol/mol, indicating reduced 
binding to NTFs in vitro, in agreement with 
previously published results (15). C1mC2-3SD 
(Fig. 2A, purple) binds NTFs with a Kd of 16 ± 5 
µmol/L, (mean ± SEM, n=4), similar to that of 
unphosphorylated C1mC2, but with a 
significantly lower Bmax, 0.51 ± 0.06 mol/mol. 
Next we tested whether S-D substitutions mimic 
the effect of phosphorylation of m-domain serines 
on the binding of C1mC2 to myosin S2∆, the first 
126 amino acids of myosin S2 (16) by Microscale 
Thermophoresis (MST). Binding of C1mC2 to 
myosin S2∆ is strongly temperature-dependent. 
At 21°C Kd was ~100 µmol/L, but at 30°C it was 
reduced to ~20 µmol/L, in agreement with 
previous results (16) (Fig. S3; Tab. 1). Moreover, 
the binding curve is biphasic, indicating an 
additional low affinity binding interaction with an 
estimated Kd of ~400 µmol/L (arrow head in Fig. 
S3).  
As a step towards localising the binding 
interactions between cMyBP-C and myosin S2∆, 
we measured the binding affinity for myosin S2∆ 
to the isolated m-motif, and to a construct 
containing Ig domains C1 and C2 connected by a 
flexible linker (C1-C2), i.e. with the m-motif 
deleted (Fig. 2B; Tab. 1). The m-motif alone 
binds myosin S2∆ with a Kd of ~40 µmol/L, 
indicating that it is the main interaction site 
between C1mC2 and myosin S2∆. In contrast C1-
C2 binds myosin S2∆ with a Kd of ~500 µmol/L, 
suggesting that the flanking C1 and C2 domains 
are responsible for the low-affinity binding sites 
in C1mC2 and only have a small contribution to 
C1mC2 binding to myosin S2∆. 
Increasing ionic strength greatly reduced the 
affinity of C1mC2 for myosin S2∆ (Fig. 2C; Tab. 
1), suggesting that the interaction between the m-
motif and myosin S2∆ is mainly ionic. Consistent 
with that interpretation, binding of the isolated m-
motif to myosin S2∆ was largely abolished at the 
higher ionic strength.   
Both PKA tris-phosphorylation and replacement 
of the three phosphorylatable serines by aspartate 
abolished the high affinity interaction between 
C1mC2 and myosin S2∆ (Figs. 2D and S4; Tab. 
1), as expected for the largely ionic nature of the 
high affinity binding site in the m-motif.  
 
Discussion 
The results presented above show that serine-to-
aspartate substitution of the three 
phosphorylation sites in the m-motif of cMyBP-
C fully mimic the effects of phosphorylation of 
those sites with respect to binding to myosin S2∆ 
but fail to mimic its effects on the interaction 
between cMyBP-C and the thin filament. The 
ionic strength dependence of the binding between 
cMyBP-C and myosin S2 suggests that it is 
mainly driven by ionic interactions between the 
m-motif and myosin S2∆, consistent with the fact 
that it can be abolished by the introduction of 
additional negative charges, by either 
phosphorylation or S-D substitutions. In contrast, 
regulatory interactions of cMyBP-C with NTFs 
have been localized to both domain C1 and the m-
motif (17). Phosphorylation of the m-motif 
serines appears to control these regulatory 
interactions by altering C1mC2 structure (18), in 
a way that is not efficiently mimicked by S-D 
substitutions. Although S-D substitutions reduce 
the binding capacity of C1mC2 to NTFs to a 
similar extent to that observed for the effects of 
PKA phosphorylation on the native protein, they 
do not affect Kd and thin filament activation, 
suggesting that phosphorylation might affect thin 
filament activation via a structural change 
communicated between the m-motif and domain 
C1 (15). 
These results in combination with previous work 
therefore suggest that: unphosphorylated native 
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cMyBP-C binds to both the thin and thick 
filaments (Fig. 3A), stabilizing their ON and OFF 
states respectively; cMyBP-C phosphorylation 
abolishes both regulatory interactions, so that 
myosin heads are released from the thick filament 
backbone but the thin filament is OFF (Fig. 3B), 
and substitution of the phosphorylatable serines 
by aspartates releases the myosin heads from the 
thick filament backbone without affecting the 
regulatory interaction with the thin filament (Fig 
3C), therefore stabilizing the ON state of both thin 
and thick filaments. It follows that it could be 
quite misleading to interpret the effects of S-D 
substitutions in cMyBP-C as reproducing the 
structural or functional effects of tris-
phosphorylation of cMyBP-C in vitro or in vivo. 
On the other hand the differential effects of S-D 
substitutions and tris-phosphorylation on the thin- 
and thick-filament interactions of cMyBP-C may 
provide a useful approach to dissect the effects of 
those interactions in future studies. 
 
Experimental procedures 
Preparation of bifunctional rhodamine labelled 
cRLC and cTnC, and exchange into 
demembranated rat ventricular trabeculae 
Wistar rats (male, 200-250 g) were sacrificed by 
cervical dislocation (Schedule 1 procedure in 
accordance with UK Animal Scientific Procedure 
Act, 1986) and demembranated right ventricular 
trabeculae were prepared as described previously 
(19). All procedures were carried out in 
accordance with the guidelines of the Animal 
Welfare and Ethical Review Body (AWERB, 
King’s College London). All animals were 
treated in accordance with the guidelines 
approved by the UK Animal Scientific 
procedures ACT (1986) and European Union 
Directive 2010/63/EU. 
Bifunctional sulforhodamine (BSR) labelled 
RLCs and bifunctional rhodamine (BR) labelled 
TnCs were prepared as previously described 
(5,19). BSR-cRLCs were exchanged into 
demembranated trabeculae by extraction in 
CDTA-rigor solution (composition in mmol/L: 5 
CDTA, 50 KCl, 40 Tris-HCl, 0.1% (v/v) Triton 
X-100, pH 8.4) for 30 min followed by 
reconstitution with 40 µmol/L BSR-cRLC in 
relaxing solution for 1 h at 22°C, replacing ~50% 
of the endogenous RLC (5). BR-cTnCs were 
exchanged by overnight soak on ice of 
demembranated trabeculae in relaxing solution 
containing 0.5 mg/ml BR-cTnCs, replacing ~70% 
of the endogenous TnCs (20). 
 
Protein preparation and phosphorylation 
All proteins were cloned from a rat cDNA library 
(BioChain) into a modified pET6a vector fused to 
an N-terminal hexa-histidine-tag followed by 
TEV cleavage site. C1mC2 serine-to-aspartate 
(S-D) mutations were introduced according to 
previously published protein primary sequences 
(8) and introduced by site-directed mutagenesis. 
Protein constructs were expressed in BL21(DE3)-
RIPL cells (Agilent Technologies) followed by 
affinity chromatography on HisTrapFF columns 
(GE Healthcare) and removal of the tag-sequence 
by TEV protease treatment. Proteins were further 
purified by ion-exchange chromatography (IEC) 
on MonoS columns (GE Healthcare), 
concentrated to >100 µmol/L, snap frozen in 
liquid nitrogen and stored in aliquots at -80°C for 
experiments. Myosin S2∆ was cloned from a rat 
heart cDNA library (BioChain) into a modified 
pET6a vector, and expressed and purified as 
described above, except that IEC was instead 
performed on a MonoQ column. Purity was 
estimated by SDS-PAGE and ESI mass 
spectrometry to >95%. C1mC2 was 
phosphorylated by protein kinase A (PKA) and 
purified as described previously (5). Briefly, 50 
µmol/L C1mC2 in PKA assay buffer 
(composition in mmol/L: 20 Tris-HCl, 50 NaCl, 
2 MgCl2, 0.1 EDTA, 1 DTT) was incubated with 
2000 U/ml of the catalytic subunit of PKA for 30-
60 min at 30°C. The reaction was followed by 
PhostagTM-SDS-PAGE and ESI mass 
spectrometry (Fig. S1). The mainly tris-
phosphorylated C1mC2 was further purified by 
IEC on MonoS, and homogeneity determined by 
PhostagTM-SDS-PAGE and ESI mass 
spectrometry to be >95%. Prolonged incubation 
of C1mC2-3P with demembranated trabeculae 
did not results in any significant protein 
dephosphorylation (Fig. S1B). For experiments, 
aliquots of proteins were thawed on ice, and gel-
filtered and dialysed against new buffer prior to 
each experiment. 
 
Fluorescence polarization experiments 
Activation protocols and composition of 
experimental solutions were identical to those 
described previously for fluorescence 
polarization experiments (21). Polarized 
fluorescence intensities were measured as 
described previously for skeletal and cardiac 
muscle fibres. Trabeculae were mounted between 
a strain gauge force transducer (KRONEX, 
Oakland, California 94602, USA; model A-801, 
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resonance frequency ~2 kHz) and motor (Aurora 
Scientific, Dublin, D6WY006, Ireland; Model 
312C). Fluorescence emission from BSR-cRLCs 
and BR-cTnCs in trabeculae was collected by a 
0.25 N.A. objective using an excitation light 
beam in line with the emission path. The 
polarization of the excitation and emitted beams 
was set either parallel or perpendicular to the 
trabecular axis, allowing determination of the 
order parameter <P2> that describes the dipole 
orientations in the trabeculae (22). The sarcomere 
length of trabeculae was measured by laser 
diffraction in relaxing solution prior to each 
activation. Activating solution contained (in 
mmol/L): 25 imidazole, 15 Na2CrP, 58.7 KPr, 
5.65 Na2ATP, 6.3 MgCl2, 10 CaCl2, 10 K2EGTA, 
1 DTT, pH 7.1. Each activation was preceded by 
a 2-min incubation in pre-activating solution 
(composition in mmol/L: 25 imidazole, 15 
Na2CrP, 108.2 KPr, 5.65 Na2ATP, 6.3 MgCl2, 0.2 
K2EGTA, 1 DTT, pH 7.1). Isometric force and 
steady-state fluorescence polarization values 
were measured once steady force had been 
established.  
 
Native thin filament co-sedimentation 
Native thin filaments (NTF) were prepared 
according to previously published protocols (23) 
and co-sedimentation experiments performed as 
described in (15). 
 
Microscale thermophoresis 
Microscale thermophoresis experiments were 
performed on a Monolith NT.115 instrument 
(NanoTemper, Cambridge CB3 0AX, United 
Kingdom) in interaction buffer containing 20 
mmol/L MOPS pH 7, 1 mmol/L EDTA, 50 
mmol/L KCl, 1 mmol/L DTT and 0.05% (v/v) 
Tween-20. Myosin S2∆ was labelled with Alexa 
647-NHS (Molecular Probes Inc, Thermo Fischer 
Scientific, Paisley, PA4 9RF, United Kingdom) 
according to manufacturer’s instructions, and dye 
incorporation (efficiency of ~80%) confirmed by 
HPLC and ESI-mass spectrometry. All proteins 
were either gel-filtered into and/or extensively 
dialysed against interaction buffer. Titration 
experiments were performed with a fixed Alexa 
647 – myosin S2∆ concentration of 100 nmol/L 
in standard treated capillaries. For experiments 
with isolated m-motif, the pH of the MST buffer 
was adjusted to 6.2 and experiments were 
performed in enhanced gradient standard 
capillaries. 
 
Statistical analysis 
Statistical significance of difference between 
groups was assessed with a one-way ANOVA 
followed by Turkey’s post-hoc test. Details of 
significance levels are shown in the figure 
captions. 
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The abbreviations used are: BSR, bifunctional sulphorhodamine; C1mC2, fragments of cardiac myosin 
binding protein-C containing the Ig-domains C1 and C2, and the intervening m-domain; cMyBP-C, 
cardiac isoform of myosin binding protein-C; cRLC, cardiac isoform of myosin regulatory light chain; 
cTnC cardiac isoform of troponin C; IT-arm, core domain of troponin containing troponin I and troponin 
T; PKA, protein kinase A; PKA, Protein Kinase A or cAMP-dependent protein kinase; S-D, serine-to-
aspartate 
 
Tables and Table Legends 
 
Table 1. Summary of equilibrium dissociation constants (Kd) for different cMyBP-C constructs for 
myosin S2∆ as measured by Microscale Thermophoresis. 
Ligand T [°C] KCl [mmol/L] Kd [µmol/L] 
C1mC2 
21 50 106.2 ± 11.2 
25 50 58.5 ± 8.5 
30 50 21.3 ± 3.5 
30 180 364.5 ± 10.6 
C1-C2 30 50 477.4 ± 6.7 
m-motif 
30 50 41.1 ± 2.3 
30 180 cd 
C1mC2-3P 30 50 cd 
C1mC2-3SD 30 50 cd 
Means ± SEM (n=4-6). cd - Kd cannot not be reliably determined 
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Figures and Figure Legends 
 
 
Figure 1. Effect of phospho-mimetic substitutions in cMyBP-C on isometric force, and thin and thick 
filament structure in cardiac muscle. (A) Schematic of cMyBP-C’s domain organisation and known 
protein interactions, with a sequence alignment for the cardiac specific m-motif containing the 
phosphorylatable serine residues (LMM, light mero-myosin; RLC, regulatory light chain; myosin S2, 
myosin sub-fragment 2). (B) Isometric force, (C) TnC probe orientation and (D) RLC probe orientation 
of ventricular trabeculae in relaxing conditions (pCa 9, green), at full calcium activation (pCa 4.5, red), 
and during incubation in relaxing solution (pCa 9) containing 40 µmol/L C1mC2 (blue), phospho-
mimetic C1mC2-3SD (turquoise) or PKA tris-phosphorylated C1mC2-3P (purple). Mean ± SEM with 
the number of trabeculae (n) indicated in each panel. Statistical significance of differences between 
groups was assessed with a one-way ANOVA followed by Turkey’s post-hoc test: *p<0.05, **p<0.01, 
***p<0.001, ns-not significant.  
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Figure 2. Binding of cMyBP-C N-terminal domains to native thin filaments (NTF) and myosin S2∆. 
(A) NTF co-sedimentation binding data for C1mC2 (red), C1mC2-3P (orange) and C1mC2-3SD 
(purple). (B) Normalized MST binding curves for C1mC2 (red), isolated m-motif (green) or C1-C2 
(blue) titrated against myosin S2∆. (C) Normalized MST curves for C1mC2 (red) and m-motif (green) 
binding to myosin S2∆ in the presence of 50 mM KCl (circles) and 180 mM KCl (squares). (D) Binding 
of C1mC2 (red), C1mC2-3P (orange) and C1mC2-3SD (purple) to myosin S2∆. For all experiments: 
Means ± SEM, n=4-8. 
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Figure 3. Model for the effect of phosphorylation or serine-aspartate substitutions on cMyBP-C 
function. (A) In the unphosphorylated state, cMyBP-C binds both thin and thick filaments stabilizing 
their ON and OFF states, respectively. cMyBP-C inhibits myosin head domains (grey) by stabilizing 
their folded OFF state and activates the thin filament by moving tropomyosin (brown) away from its 
blocked position towards the open position. (B) PKA tris-phosphorylation (P) abolishes both the 
activating and inhibitory effects of cMyBP-C on the thin and thick filament, respectively. (C) In 
contrast, serine-to-aspartate substitutions (D) abolish the inhibitory interaction between cMyBP-C and 
myosin, but do not abolish the activating interaction with the thin filament.    
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